| Human Molecular Genetics | Pages |
The embryonic expression pattern of 40 murine cDNAs homologous to Drosophila mutant genes (Dres): a comparative and topographic approach to predict gene function
Introduction
Results
General strategy
Patterns of expression observed
Discussion
Expression analysis of Dres genes
Expression pattern conservation
Expression analysis and genetic programs
Expression analysis and disease gene identification
Expression analysis and mouse models
Expression database
Materials And Methods
Bioinformatics
Murine cDNA clone retrieval and characterization
In situ hybridization
Acknowledgements
References
The embryonic expression pattern of 40 murine cDNAs homologous to Drosophila mutant genes (Dres): a comparative and topographic approach to predict gene function
INTRODUCTION
We are rushing into an exciting era in which tens of thousands of novel human genes are being identified by large scale cDNA and genomic sequencing projects. Over 1 000 000 human expressed sequence tags (ESTs) generated from a large variety of human tissue sources (1-7) and possibly corresponding to >40 000 human genes are available in a public database (dbEST) (8). This database is, in fact, the major source of novel genes with potentially important biological functions. Nevertheless, a difficult task arises from this abundance: how to systematically analyze genes in order to begin unraveling their function. The gap between the amount of data generated by collective sequencing and mapping efforts and the capability of assigning a function to a novel sequence is widening, especially at the level of the whole organism. For these reasons, a new and challenging period is approaching (9,10).
Cross-species comparison represents an effective strategy to investigate the function of genes (11-15). For example, analysis of a number of genes conserved between yeast and man has provided striking insights into their function (12,16). Our extensive knowledge of the function of Drosophila genes can also facilitate comprehension of the role of their mammalian homologs. Despite the remarkable evolutionary distance between man and Drosophila, a number of genes are highly conserved between humans and the fruit fly and exert similar functions in the two species. The phenotypes caused by mutations in some of these genes can affect related systems and organs in both man and fly (17,18). For example, the human gene responsible for aniridia (PAX6) is homologous to the Drosophila eyeless gene (18). Recently, we performed a systematic identification of human cDNAs homologous to Drosophila mutant genes (19-21). To date, we have identified >150 novel human genes which we named DRES (Drosophila-related expressed sequences). The significant degree of conservation of these cDNAs throughout evolution suggests that they encode molecules with key biological functions.
A detailed analysis of gene expression distribution is of crucial importance in order to understand the physiological role of a given gene/protein in a living organism. Most genes affect different aspects of the cellular and tissue phenotype. This pleiotropic effect originates when a protein or mRNA is necessary at different sites and/or at different times. Consequently, we need a way to systematically investigate gene expression in developing organs and tissues to document when and where genes are functioning. A detailed temporal and spatial investigation of gene expression will also provide insight into gene product interactions and perhaps indicate hierarchies in gene expression programs. Furthermore, a complete identification of expression domains could be useful for the development of new therapeutic tools and to help estimate their potential side effects.
Several systematic strategies have been developed to establish time, location and level of gene expression. `Digital northerns' or `transcript profiles' are either produced by sequencing thousands of cDNA clones from different tissues and expression is correlated with variation in the relative frequency of sequence tags of the transcript of interest (4,22,23) or else they are based on hybridization to arrayed oligonucleotides (24) or to cDNA libraries (25-27). These `low resolution' expression screens based on EST programs lack the necessary resolution to define the expression profile in the context of a developing or fully differentiated tissue, organ or organism. In fact, they provide a combined expression profile of all cells in the sample under study. These methods are then more appropriate to delineate expression in cultured cell lines, for example in two cellular differentiation systems inducible in vitro. If expression is to be viewed in original tissues and in cell populations that are spatially restricted, or, on the other hand, if simultaneous expression must be studied in distant regions or structures, then low resolution expression screens are not appropriate. A high resolution analysis of gene expression can be performed by RNA in situ hybridization. The advantage of this technique is that it allows the localization of gene expression at the cytological level, which is confined to a few cells or cell layers at a specific time and simultaneously in the entire developing organism. In other words, it allows a very accurate analysis of the spatial and temporal pattern of distribution of gene transcripts (28).
To combine the value of comparative analysis with the contribution of gene expression studies, we performed a detailed and systematic high resolution expression study by RNA in situ hybridization on a subset of murine homologs of human Dres genes.
RESULTS
General strategy
A searchable database termed the DRES search engine has been created and is accessible through the TIGEM DRES home page (http://www.tigem.it/dros.html ). The database, periodically updated, contains a collection of TBlastN outputs and can be extensively searched in several ways: (i) with Drosophila protein accession numbers or IDs; (ii) with the progressive index number; or (iii) with a range of P values for the best matching EST sequence in the output (19-21). Until now, >150 DRES genes have been identified using the DRES search engine. In terms of sequence conservation, all DRES show a high degree of similarity with the corresponding Drosophila homologs, with P values ranging from 1.4e-70 to 1.1e-6.
Murine homologs of DRES genes (Dres) were systematically searched by sequence database screening and by standard experimental approaches. Bioinformatic searches were performed using the BlastN algorithm against dbEST, which now contains >300 000 mouse ESTs, mostly generated by the WashU-HHMI Mouse EST Project (6,7). Over 80% of murine cDNAs were identified by bioinformatic analysis, while the others were isolated by screening of murine cDNA libraries and by PCR amplification of murine genomic DNA. Overall, we have identified >80 murine homologs of DRES genes. The level of nucleotide homology between human and murine Dres ranged from 82 to 97% identity.
More than 30 murine Dres were also mapped and the position of each was found to be syntenic to that of human homologs, thus confirming that the murine genes were indeed the orthologs of their human counterparts. In Table 1, Dres genes analyzed in this study are arbitrarily divided into five subgroups, based on phenotypic information of the corresponding Drosophila mutants: segmentation and development, eye-related, neural development, sex determination and reproduction and others. For each Dres, the name and the sequence accession number of the corresponding full-length cDNA (if known) is reported, as well as the sequence accession number of the probes used for the in situ experiments.
To systematically and comprehensively document expression patterns of Dres murine homologs, we collected a standard series of sections of mouse embryos at three developmental stages, E10.5, E12.5 and E17.5. These stages, which correspond to the late embryonic and fetal human period, cover the time when most major organs and body regions are organized and become functional. Each slide series consists of sections of embryos cut in the sagittal, coronal and transverse planes.
Antisense and sense radioactive riboprobes, mostly originating from the 3[prime]-untranslated region (the least conserved among gene families) of murine EST clones, were used for hybridization. Whole mount in situ hybridization was also systematically performed at earlier stages (E8.5, E9.5 and E10.5) when transcripts were detected at E10.5 by radioactive in situ hybridization on sections. In a few cases, tissues that have a prolonged period of development, such as the brain and eye, were also analyzed postnatally. The slides and stained embryos were then subjected to a detailed analysis. Panels of images for any relevant in situ hybridization experiment were generated for each Dres gene and stored in a local database.
Dres were selected on the basis of an intriguing phenotype of the corresponding Drosophila mutants, an attractive human or murine mapping assignment and an interesting type of encoded protein. Particular importance was given to Dres homologs of Drosophila mutant genes with an eye-related or developmental phenotype (Table 1).
Table 1.
| Dres | Drosophila Gene |
Type of protein | Mouse Gene |
Accession no. | in situ probe |
| Developmental | |||||
| 115 | BarH1 (mouse) | homeodomain containing protein | - | - | W36375 |
| 46 | Bicaudal C | putative RNA binding domain | - | - | AA028383 |
| 45 | Bithorax complex | adenosylhomocysteinase | - | - | AA103383 |
| 44 | bithoraxoid | - | - | - | AA403393 |
| 129 | caupolican | homeodomain containing protein | iroquois homeobox protein 3 | Y15001 | W41873 |
| 93 | empty spiracles | homeodomain containing protein | - | - | Y18247 |
| 14 | fat facets | ubiquitin C-terminal hydrolase | fat facets homolog (Fam) | U67874 | AA260311 |
| 48 | fringe | cell-signalling molecule | radical fringe | AF015770 | W83195 |
| 42 | frizzled | transmembrane domain | frezzled | U68058 | AA278065 |
| 124 | muscleblind | ring-finger protein | - | - | AA250561 |
| 52 | pumilio | - | - | - | AA144200 |
| 56 | rotund | GTPase activating protein | - | - | AA124923 |
| 30 | Serrate | Notch ligand | jagged2 | Y14495 | Y14331 |
| 118 | sister of odd and bowel | C2H2 zinc finger | - | - | AA003288 |
| 55 | Suppressor of hairless | J Kappa recombination signal binding protein | - | - | Y18248 |
| 144 | trithorax protein ASH2 | - | - | - | AA089069 |
| Eye Related | |||||
| 91 | CDS=photoreceptor-specific | CDP-diacylglycerol synthase | - | - | AA170489 |
| 92 | CDS=photoreceptor-specific | CDP-diacylglycerol synthase | - | - | W30593 |
| 155 | eyes absent | - | Eya1 | Y10263 | W34432 |
| 67 | eyes absent | - | Eya3 | U61112 | AA049689 |
| 119 | eyes absent | - | - | - | Y17115 |
| 16 | nemo | serine/treonine kinase | nemo-like kinase (Nlk) | AF036332 | AA764140 |
| 156 | norpA | phospholipase C | - | - | W50364 |
| 17 | prune | GTPase activating protein | - | - | AA547423 |
| 8 | retinal degeneration A | diacylglycerolkinase | - | - | AA472764 |
| 9 | retinal degeneration B | phosphatidylinositol transfer protein | Dres9 | Y08922 | X98655 |
| 10 | retinal degeneration C | phosphoprotein | Ppef | - | Y08234 |
| Neural development | |||||
| 32 | bendless | ubiquitin-conjugating enzyme | - | - | AA982879 |
| 27 | minibrain | serine/threonine kinase | - | - | AA589241 |
| 65 | Ras opposite | vesicular trafficking protein | unc-18 homologue | D45903 | AA049343 |
| Sex determination and reproduction | |||||
| 23 | male lethal 3 | - | - | AA575543 | |
| 147 | Rga | transcriptional regulator | - | - | W36804 |
| 140 | angel | - | - | - | AA050900 |
| 131 | Des-1 | transmembrane protein | Mdes transmembrane protein | Y08460 | AA035819 |
| 25 | diaphanous | FH1-FH2 domains | - | - | AA920816 |
| 86 | diaphanous | FH1-FH2 domains | p140mDia | U96963 | W67065 |
| Others | |||||
| 61 | Eag-like K[+] channel | putative potassium channel | - | - | W51365 |
| 139 | kekkon-2 (mouse) | immunoglobulin superfamily | - | - | AA153559 |
| 134 | Past1 | ATP/GTP binding site | - | - | AA051670 |
| 132 | TBP-associated factor 150kD | TATA-binding protein associated factor | - | - | AA028778 |
The in situ hybridization results are summarized in Table 2. The expression profile is schematically illustrated in the last column, where the different systems and parts of the mouse embryo are listed. The distribution of expression data is represented by organ systems and not by embryonic regions or structures, as most of the steps of morphogenesis and organogenesis have already occurred in the stages that were analyzed (E10.5-E17.5). Separate columns highlighting expression in developing limbs and head have been added, mainly because these structures have complex developmental processes involving large networks of interacting gene products. Two arbitrary levels of gene expression (low and high) are reported. It is also emphasized when regional domains of expression are detected in particular organs, as in the case of Dres93, for which expression is found in defined areas of the developing brain and retina.
Patterns of expression observed
The expression distribution of Dres genes reported and summarized in Table 2 can be compiled in several categories: undetectable, ubiquitous, organ-specific and domain- or region-specific. Examples of the data described below are shown in Figures
Figure 1. Examples of Dres expression in multiple organs. (A) Complex Dres118 expression in the craniofacial mesenchyme and digestive tract in an E12.5 embryo, sagittal section. (B) Transverse hand plate section of E12.5 embryo showing the expression of Dres118 in the mesenchyme surrounding the condensating cartilage. (C-G) Dres139 expression. (C) Sagittal section of the head of an E17.5 embryo. (D-G) High magnification views in panels showing strong expression in the vibrissae (D), in the tooth buds (E), in the tip of the developing digits (F) and in the sinus hair follicles (G). CC, condensating cartilage; T, telencephalon; E, eya; TB, tooth bud; VF, vibrissae follicles; SHF, sinus hair follicle; BB, basisphenoid bone. Table 2.
More restricted expression patterns were observed for: prune/Dres17 (central and peripheral nervous system, retina and limb buds), Bithorax complex/Dres45 (central and peripheral nervous system and maxillary mesenchyme), sister of odd/Dres118 (branchial arches, limbs, midgut, stomach, omentum and cranial mesenchyme; Fig.
Figure 2. (A and B) Dres expression in specific organs. (A) Dres61 transcript is specifically detected in the developing thyroid, as shown on this E10.5 coronal section. (B) Sagittal section at E12.5 showing Dres92 expression in the thymic anlage. (C-F) Examples of expression conservation betweenDrosophila and mouse: Dres65 and Dres91. (C) Sagittal section of an E12.5 embryo showing Dres65 expression in the entire central nervous system. High magnification showing expression in the post-mitotic neurons of thetelencephalic mantle (D), nasal epithelium and vomero-nasal organ (E). (F and G) Sagittal section of an E16.5 embryo showing the expression of Dres91 in the central nervous system and specifically in the inner neuroblast layer of the neural retina. TR, thyroid primordium; TM, thymic primordium; T,telencephalon; D, diencephalon; M, mesencephalon; Rh, rhombencephalon; CC, cerebral cortex; TV, telencephalic vesicle; OP, olfactory epithelium; VO, vomero-nasal organ; ONL, outer neuroblastic layer; INL, inner neuroblastic layer. Few Dres show discrete domains of expression in particular organs. Dres115, the homolog of BarH1, and Dres93, the homolog of empty spiracles, are expressed in highly defined regions of the central nervous system and neural retina, respectively. As shown in Figure Figure 3. Specific distribution of Dres transcripts in the developing neural retina. Sagittal sections of E12.5 embryos. Dres16 (A) and Dres9 (B) are expressed in the entire neural retina; but while Dres16 transcript distribution is uniform, Dres9 shows prevalent expression in the outer proliferative neuroblast layer. Dres93 (C) expression is peculiarly confined to the whole inferior portion of the neural retina. Dres65 (D), Dres45 (E) and Dres129 (F) are exclusively expressed in the inner layer of differentiating neuroblasts along the gradients of differentiation, from the inner to the outer layers and from the center to the periphery. Dres45 (E) is also expressed along radial columns of cells in the outer, proliferative neuroblast layer. OpS, optic stalk; ONL, outer neuroblastic layer; INL, inner neuroblastic layer; L, lens. Figure 4. Early expression assessed by whole mount in situ hybridization. (A) Dorsal view of Dres129 expression at the neural plate stage (E8.0): specific signal is detected in the neural fold apposition, in the lower cervical region; in a restricted domain of the neuroepithelium in the prospective hindbrain region and in the underlying cephalic mesenchyme. (B) Dres93 expression is confined at E9.0 to the inferior part of the optic cup. (C) Dres115 is specifically expressed at E9.0 in a region corresponding to the anlage of the diencephalon and in the most dorsal part of the alar plate along the hindbrain and the spinal cord. CM, cephalic mesenchyme; Hb, hindbrain; NFA, neural fold apposition; OC, optic cup; PV, prosencephalic vesicle; D, dincephalon; M, mesencephalon; Rh, rhombencephalon; SP, spinal cord.Early expression. The analysis was also extended to early stages of development for Dres genes expressed at E10.5. These whole mount in situ hybridization experiments turned out to be very informative for Dres129, Dres115 and Dres93. Dres129 transcripts are detected at E8.5 in the cephalic neural folds and underlying mesenchyme (Fig.
DISCUSSION
Expression analysis of Dres genes
The sequence of a significant number of human genes can be found in publicly available EST databases. One of the major challenges of biomedical research for the next decade will be to identify systematic approaches to help understand their function (10). An obvious and productive shortcut to this goal is to start characterizing human genes sharing sequence similarities with those for which a functional characterization has already been performed in other species. This was the idea behind the DRES project: to study human genes showing significant sequence identity to Drosophila mutant genes (19-21). We wanted to take advantage of the functional studies (e.g. biochemical analyses and characterization of mutant phenotypes) previously performed in another organism to study the function of an interesting subset of human genes.
Sequence similarity often corresponds to the structural relationship of the predicted protein products, suggesting that the biochemical functions performed are also similar. However, due to the major changes that have occurred during evolution, leading to striking anatomical and physiological differences between man and fly, the physiological roles of related genes/proteins can be completely different in the two species, even if their biochemical function has been conserved. Nature often uses the same `core groups' of interacting genes or `pathways' in completely different organs, tissues or cellular compartments. It is, therefore, critical to understand not only how a gene/protein works but also where (i.e. in which tissue/organ) and when (i.e. at what developmental stage) it exerts its function. One way to achieve this is to analyze gene expression patterns at different stages during development. This study demonstrates both the feasibility and value of using RNA in situ hybridization for the systematic analysis of gene expression. Obviously, optimization of the speed of each step involved in the process and the use of automation would significantly increase the number of genes tested. Exploring the complexity of the spatial and temporal distribution of expression of Dres genes has provided us with very useful information on several aspects of gene function, which are discussed below.
Expression pattern conservation
For some Dres genes, we found a clear conservation of expression pattern in related structures between mouse and Drosophila. For example, the Drosophila gene Ras opposite (32,33) is highly expressed in the nervous system, where its product acts as a modulator of neurotransmitter release. Similarly, Dres65, highly homologous to Ras opposite, is exclusively expressed in neural tissue in the mouse (Fig.
It is indeed remarkable that some Dres genes, which are defined by a highly significant sequence homology with Drosophila, often have a similar pattern of expression and exert related biological functions in the development of the metazoan body plan. On the other hand, we found several examples of Dres genes with expression patterns that are strikingly different between mouse and Drosophila. For example, the Drosophila retinal degeneration (rdg)A, rdgB and rdgC genes are strongly expressed in the retina and are involved in the degeneration of photoreceptors (40-42). Expression patterns observed for their respective murine homologs, Dres8, Dres9 and Dres10, suggest different roles for these genes in mammalian development. Dres9, being predominantly expressed in the neural retina, has an expression pattern remarkably similar to rdgB (43). Instead, Dres8 and Dres10 have patterns of expression unequivocally different from their relatives rdgA and rdgC. The Dres8 transcript is detected in a variety of tissues, including the nervous system, gut and vibrissae follicles and Dres10 is restrictively expressed in the peripheral nervous system, within sensory neurons of neural crest origin (44). The fact that the expression patterns of Dres8 and Dres10 are not conserved suggests that their functions have been recruited in other tissues for a novel specialized use.
Expression analysis and genetic programs
A systematic, high resolution expression analysis of developmentally regulated genes can also contribute to the definition of cell types and stages and to the definition of the genetic program underlying the development of complex structures, such as the eye. Among the collection of Dres genes analyzed in this study, several were found to be expressed in the neural retina. However, the spatial distribution of gene expression observed was diverse, in some cases showing layer-specific expression patterns and the presence of boundaries of gene expression. Figure
Expression analysis and disease gene identification
Several genes responsible for human disease have already been identified through the screening of EST databases (11,45,46). In these cases, disease gene identification is usually based on the so-called positional candidate gene approach, which relies on the association of positional and functional data (47), i.e. the co-localization of a disease locus and a gene with a suggestive pathogenetic role in the disease phenotype. On the same basis, DRES can be considered potential candidate genes for human diseases. Some DRES genes have already been found to be involved in human disorders, such as the RIEG gene (DRES112), a novel homeobox gene similar to the Drosophila orthodenticle and aristaless genes, found to be mutated in Rieger syndrome (48).
Even if there are examples in which the disease phenotype reflects only a subset of the tissues which express the gene, such as the CBP gene mutated in Rubinstein-Taybi syndrome (49), the knowledge of gene expression patterns contributes significantly to the positional candidate approach by pointing to a dysfunction of a particular organ or tissue. For example, a promising `positional candidate' disease gene identified in this study is Dres119, a fourth human homolog of the Drosophila eyes absent gene. In the mouse we found Dres119 to be expressed in craniofacial mesenchyme, external auditory meatus, dermomyotome, kidney and limbs. Its human counterpart, DRES119, maps to chromosome 6q23, making it a suitable candidate for oculodentodigital syndrome (ODD), an autosomal dominant disorder previously mapped to the same region and affecting development of the face, eyes, limbs and dentition (50). Another candidate disease gene is Dres139, the homolog of the Drosophila kekkon gene, which may be involved in Cornelia de Lange syndrome, characterized by distinctive facial features such as micrognathia, hirsutism, synophrys and bushy eyebrows, low anterior hairline and small teeth, in association with growth and mental retardation, upper limb and digital defects (i.e. short tapering fingers) and delayed skeletal maturation. The transcript distribution for Dres139 is highly restricted to developing cranial and thoracic bones, vibrissae and sinus hair follicles, tooth buds and in the tip of the digits (Fig.
A possible involvement of certain DRES genes in particular disorders can also be hypothesized solely on the basis of their expression, especially if expressed in specific organs, such as Dres61, Dres92 and Dres93. The Dres61 transcript, an Eag-like potassium channel, could be detected exclusively in the primordium of the thyroid (Fig.
Expression analysis and mouse models
The data obtained from systematic high resolution expression studies will certainly add important biological information to the creation and use of the preferred model for mammalian development, the laboratory mouse. Recently, there has been dramatic progress in the efficiency of methods addressing gene function in mouse. Positional cloning of mouse mutant genes, induction of new mutants by chemical mutagenesis, targeted mutation by homologous recombination, analysis of polygenic traits and comparative gene mapping are some of the strategies being used to study the phenotypic effects of mutation of specific murine genes (51). A study of the spatio-temporal transcript distribution is the first requirement in order to fully comprehend which cell types, developmental stages and cellular processes can be altered by the mutation, as well as the compensatory effects that may be due to expression of related genes.
Furthermore, systematic RNA in situ hybridization may provide very useful information in order to choose which mouse genes would be more interesting targets for gene inactivation strategies. Recently, systematic targeted mutagenesis approaches have made possible the creation and storage of several thousand ES cell lines each carrying a knock-out of a different gene (52). Many of these genes are unknown. Therefore, knowing the expression patterns of these genes would be of great value before deciding on the generation of null mutant mice.
Expression database
To store, group and search the data obtained in this initial expression study and especially in light of the next phase of large scale data collection, we will deposit the complete expression profiles as edited panels of captured in situ images in the existing DRES database (20), accessible through a World Wide Web interface (http://www.tigem.it/dros.html ). To effectively integrate the high resolution expression data with the extensive structural documentation on genes available in public repositories, we are also planning to submit the expression profiles to the comprehensive Mouse Gene Expression Information Resource (MGEIR) through the mouse GXD Gene Expression Database, both of which are currently under development (53-55).
The comparative approach initiated with the DRES genes, in structural (sequence homology) and functional (expression analysis) terms, represents an effective strategy to obtain useful information on gene function. Moreover, the results have important implications regarding both mouse developmental biology and the evolutionary conservation of genes that orchestrate the development of the metazoan body plan. It is conceivable that all metazoans have a set of core biochemical processes and that duplicated mammalian pathways have adapted to specialized biological functions. If high resolution expression studies are applied on a large scale to ESTs and the information is comprehensively collected in databases, it will then be possible to scrutinize their sequence and/or expression patterns for particular motifs. These data will provide an essential directory to compare sequence similarities with temporal and spatial patterns of gene expression. Ultimately, this information may be of considerable help in predicting clinical consequences of gene dysfunction.
MATERIALS AND METHODS
Bioinformatics
EST entries, including homology data, were retrieved from dbEST (8). Computational analysis of EST sequences was performed using the Blast basic local alignment search tool (56), either at TIGEMNet (http://www.tigem.it ) or at the National Center for Biotechnology Information (NCBI), National Library of Medicine (http://www.ncbi.nlm.nih.gov/Recipon/bs_seq.html ).
Murine cDNA clone retrieval and characterization
EST cDNA clones were obtained from IMAGE Consor-tium Clone Distributors (http://www-bio.llnl.gov/bbrp/image/idist_add.html ). Automated fluorescent DNA sequencing was performed using Perkin Elmer 377 Prism machines with both the dye terminator and dye primer cycle sequencing chemistries on double strand plasmid templates.
In situ hybridization
Expression was detected in tissue sections of E10.5, E12.5 and E17.5 mouse embryos using radioactive in situ hybridization according to a published protocol (57). Embryos, embedded in paraffin, were fixed in 4% paraformaldehyde in phosphate-buffered saline. Sets of serial sections cut in three different planes (sagittal, coronal and transverse) covering the entire embryos were hybridized with [35S]UTP-labeled antisense or sense riboprobes. The probes were transcribed from the 3[prime]-untranslated region of the murine ESTs. Sense probes did not show any specific hybridization. Slides were counterstained in Hoechst 33258 dye to stain the cell nuclei. The resulting red color represented the hybridization signal.
The whole mount in situ hybridization experiments on E8.0, E9.5 and E10.5 mouse embryos were performed as previously described using digoxygenin-labeled RNA antisense and sense probes (58). Panels for Figures
ACKNOWLEDGEMENTS
We wish to thank Gyorgy Simon and Alessandro Guffanti for bioinformatic support, Massimo Zollo and the TIGEM Sequen-cing Core and Melissa Smith for preparation of this manuscript. We thank Dado Boncinelli, Anna Stornaiuolo, Giovanni Lavorgna, Branca Dabovic, Massimo Zollo, Loris Bernard, Giorgio Casari, Annibale Puca and Cinzia Sala for support and sharing unpublished data. The financial support of the Italian Telethon Foundation (grant no. B.37), the Merck Genome Research Institute (grant no. 37 to A.B.) and the EC (grant no. BMH4-CT97-2341 to A.B.) are gratefully acknowledged.
REFERENCES
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 13 Nov 1998
Copyright©Oxford University Press, 1998.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This Article ![]()
![]()
Abstract
![]()
FREE Full Text (PDF)
![]()
Alert me when this article is cited
![]()
Alert me if a correction is posted
![]()
Services ![]()
![]()
Email this article to a friend
![]()
Similar articles in this journal
![]()
Similar articles in ISI Web of Science
![]()
Similar articles in PubMed
![]()
Alert me to new issues of the journal
![]()
Add to My Personal Archive
![]()
Download to citation manager
![]()
Search for citing articles in:
ISI Web of Science (5)
![]()
Request Permissions ![]()
Google Scholar ![]()
![]()
Articles by Bulfone, A.
![]()
Articles by Ballabio, A.
![]()
Search for Related Content
![]()
PubMed ![]()
![]()
PubMed Citation
![]()
Articles by Bulfone, A.
![]()
Articles by Ballabio, A.
![]()
Social Bookmarking ![]()
![]()
What's this?